OPERATING SEGMENTS AND GEOGRAPHIC INFORMATION (Tables)

6 Months Ended

Jun. 30, 2020

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2019 net sales and oeprating income

	December 31, 2019
									Discontinued
	2019 Reported					Fixed	2019 Reported		Operations and	2019 Revised
	Valued at 2019		Segment		Currency		Valued at 2020		Related Allocation	Valued at 2020
(millions)	Management Rates		Change		Rate Change		Management Rates		Charges	Management Rates
Net Sales
Global Industrial		$5,569.9		$479.2		$(52.7)		$5,996.4	$(1.8)	$5,994.6
Global Institutional		5,235.5		(800.1)		(23.3)		4,412.1	-	4,412.1
Global Healthcare and Life Sciences		-		991.7		(12.7)		979.0	-	979.0
Upstream Energy		-		2,350.0		2.9		2,352.9	(2,352.9)	-
Global Energy		3,334.0		(3,334.0)		-		-	-	-
Other		907.5		313.2		(9.0)		1,211.7	-	1,211.7
Subtotal at fixed currency rates		15,046.9		-		(94.8)		14,952.1	(2,354.7)	12,597.4
Effect of foreign currency translation		(140.6)		-		94.8		(45.8)	10.4	(35.4)
Consolidated reported GAAP net sales		$14,906.3		$-		$-		$14,906.3	$(2,344.3)	$12,562.0
Operating Income
Global Industrial		$854.7		$133.4		$(7.5)		$980.6	$(77.9)	$902.7
Global Institutional		1,042.2		(93.4)		(1.5)		947.3	(7.5)	939.8
Global Healthcare and Life Sciences		-		136.7		(1.6)		135.1	(10.6)	124.5
Upstream Energy		-		188.2		(0.3)		187.9	(187.9)	-
Global Energy		379.1		(379.1)		-		-	-	-
Other		167.3		14.2		(0.9)		180.6	(13.6)	167.0
Corporate		(409.1)		-		1.2		(407.9)	128.2	(279.7)
Subtotal at fixed currency rates		2,034.2		-		(10.6)		2,023.6	(169.3)	1,854.3
Effect of foreign currency translation		(20.4)		-		10.6		(9.8)	0.7	(9.1)
Consolidated reported GAAP operating income		$2,013.8		$-		$-		$2,013.8	$(168.6)	$1,845.2

Schedule of financial information for each of the entity's reportable segments

	Second Quarter Ended				Six Months Ended
	June 30				June 30
(millions)	2020		2019		2020		2019
Net Sales
Global Industrial		$1,475.6		$1,500.7		$2,919.2		$2,897.7
Global Institutional		722.4		1,112.5		1,794.5		2,132.7
Global Healthcare and Life Sciences		307.6		252.8		554.1		479.8
Other		247.1		306.2		524.7		580.9
Corporate		12.3		-		12.3		-
Subtotal at fixed currency rates		2,765.0		3,172.2		5,804.8		6,091.1
Effect of foreign currency translation		(79.3)		(3.1)		(98.5)		2.7
Consolidated reported GAAP net sales		$2,685.7		$3,169.1		$5,706.3		$6,093.8
Operating Income
Global Industrial		$283.0		$220.9		$489.6		$382.3
Global Institutional		(37.0)		234.4		145.4		409.2
Global Healthcare and Life Sciences		65.6		31.2		88.5		56.0
Other		21.3		41.8		42.9		67.5
Corporate		(126.7)		(62.7)		(181.3)		(136.1)
Subtotal at fixed currency rates		206.2		465.6		585.1		778.9
Effect of foreign currency translation		(14.2)		(1.2)		(16.9)		(0.9)
Consolidated reported GAAP operating income		$192.0		$464.4		$568.2		$778.0